Case Study

The $400K signal: What six months of Leap data says about the specialty drug trend

auyeHCaax9PXF9 k CareGuidewithamember photo care guide photo 1 image

An employer offering a self-funded health plan came to Leap facing double-digit specialty trend, driven largely by therapies like Ocrevus, Darzalex Faspro, and Keytruda. 

The reason that trend runs so far ahead of the rest of medical spend is not the drugs themselves. It is buy-and-bill markup, the practice of billing a single bundled claim that hides the drug cost, the administration fee, and the provider's margin behind one allowed amount.

Leap's claims analysis for this employer found markups running as high as 400%, with some members' medications marked up by as much as $250,000 a year, on top of the personal cost of long commutes and missed work their members were already experiencing.

The six-month result

Just six months after launching, Leap is delivering $400,000 in annualized savings per 10,000 covered lives. And member engagement is still ramping up. The employer is on track to reach $800,000 saved per 10,000 lives by year-end, as outreach shifts from broad activation toward engaging the smaller subset of members who account for a disproportionate share of specialty drug spend.

VKYZi8vuLeBvN8he %24400Kto%24800Kper10Kcoveredlives savings band 1 image

The member-level numbers back up the trajectory. The employer's Net Promoter Score sits at 100, against an industry average of roughly 30. Member satisfaction is 98%. And 80% of members who connected with a Care Guide chose Leap to support their infusion care.

There are a variety of engagement levers that can be pulled to drive savings. Among employers with Leap, those who:

  • Relied on passive enrollment typically saw 10% to 20% member utilization.
  • Provided financial incentives saw member utilization rates of 35% to 40%.
  • Embedded Care Guide consultations directly into the prior-authorization process pushed utilization past 60%. 

This employer's result reflects the value of engagement levers.

Tangible efforts that moved the needle

The employer and Leap built a thoughtful activation strategy, which included: 

  • Co-branded announcements and webinars that put Leap where members already go to find care.
  • Integration with a navigation partner so referrals happen at the point of need.
  • A custom prior-authorization flow to expedite decisions. 
  • Financial incentives including waived copays.

How one family experienced better care

One of this plan’s employees received Gammagard infusions for a rare autoimmune disease. Twice a month, she and her husband would drive two hours round-trip to an infusion center. The husband took two half-days off work on back-to-back days every other week to support her. Between the drive, the waiting room, and insurance approvals, infusion day had become stressful in ways that went well beyond her own recovery.

Within a few weeks of launching Leap benefits, she was receiving the same Gammagard infusion at home, on a schedule built around her schedule, with no copay. 

uAkU2t9Q1peIA0Q7 CareGuidejourney care guide journey 1 image

A Leap Care Guide:

  • Handled the prior authorizations.
  • Coordinated medication shipments.
  • Kept treatment on schedule so the family didn't have to manage it themselves. 

As the member put it: "I've been an IVIG patient for several years and dealt with many companies. Leap by far has been the most reliable, and I owe them gratitude because if it wasn't for them, I would not be able to do my day-to-day life as I am able to today."

When price transparency and the employee experience meet

This is what 80% Care Guide conversion and 98% satisfaction can look like. The savings figure and the member experience contribute to the same outcome.

NMqUif6NrrnpCguA Memberengagementforthisemployer engagement stats 1 image

Transparent pricing creates the opportunity, but engagement is what turns that opportunity into realized savings and satisfied members. The employer that gets members to a Care Guide earlier is the employer that captures the larger savings number.

Want to see what this looks like against your own claims data? 

Share this post

More insights

4fgyyvwF4RbiP1Ge Photo05%E2%80%94nursecheckingtheIVsite leap 05 nurse checking iv site 4962x2439 image
Infusion care

Is home infusion right for every patient? Here’s who decides

When patients learn they can receive their infusions at home, they might reasonably ask: Can I start...

Read article
uGsQNuRFuKAhTzKX benefits leader a reviewing report image
Education

Your guide to J-codes in medical billing, and what they can hide

An employer’s specialty trend was running at double digits, driven largely by therapies like Ocrevus...

Read article
gr 7yJaj1xLjiPDQ inside nurseadjustingIVdripforseniorpatientathome image
Education

Want to increase member participation in a specialty medicine solution? Reducing or waiving cost share is a good start.

One employee at a self-funded employer received Gammagard infusions twice a month for a rare autoimm...

Read article
A2LILi0roy6lnpj7 task export 6 image
Education

6 specialty medicine trends for 2027 and what they mean for benefits leaders

If it feels like specialty medicine is changing faster than your benefits strategy can keep up, that...

Read article
qmQqiddpjKSpw85s HRprofessional%E2%80%94intheoffice hr professional 3 office image
Education

Healthcare point solutions: What they are and 5 questions when evaluating them

If every healthcare point solution delivered the return in its sales deck, employer health costs wou...

Read article
XC0BuEWYGds6rfBI WeInfusepartnershipbloggraphic PNG%2C4962%C3%972439%2C300PPI 1 image
News

Leap expands specialty infusion network with WeInfuse collaboration

Leap is expanding its employer specialty infusion network through a new collaboration with WeInfuse,...

Read article
mIVvKbrIeVcspajE Spring Fall couplesittingtogetherongardenbenchwithcoffee image
Insights

Infusion vs. injection: Breaking down the basics of these two specialty therapies

In 1995, there were about 30 specialty drugs on the market. Today, there are nearly 1,000, and rough...

Read article
EJGfZMLy5m1bnieu inside closeupivdripformingdropletinhospital image
Insights

Let's blow up the buy-and-bill drug model: How it works and what it costs employers

Twice a year, a member with multiple sclerosis (MS) sits down for an Ocrevus infusion. The drug is t...

Read article
aVrzVnNYClf9oxJK Leap MS image
Insights

The real cost of MS infusion therapy and how a better member experience can bring down costs

For two years, Maria drove two hours each way for her multiple sclerosis (MS) treatment. Every appoi...

Read article
Oncology biosimilars market
Education

The emerging oncology biosimilars market and how employers can prepare.

A member who starts Keytruda today will likely organize the next two years of their life around it. ...

Read article